The Utility of a Model-Based Cost-Effectiveness Analysis of Degarelix Versus Leuprolide in the Therapy of Hormone-Dependent Advanced Prostate Cancer. FE 2013, 14 (3), 131-146. https://doi.org/10.7175/fe.v14i3.700.